The Patellofemoral Pain Functional Performance Study

Patellofemoral Pain Clinical Trial

— PFP-FP  

Official title:

The Patellofemoral Pain Functional Performance and Arthrogenic Muscle Inhibition Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02914574
• Other study ID #: HSCR15-143
• Status: Completed
• Phase: N/A
• First received: September 22, 2016
• Last updated: March 15, 2018
• Start date: June 2016
• Est. completion date: October 2017

Study information

• Verified date: March 2018
• Source: University of Salford
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study primarily aims to investigate arthrogenic muscle inhibition (AMI), an underlying mechanism in patellofemoral pain (PFP), which remain to date understudied. Although, studies have revealed that AMI needs to be eliminated before improvements in muscle strength can be achieved, to date quadriceps muscle inhibition in patients with PFP remains understudied. To date the influence of AMI on functional performance and the direct link to pain in patients with PFP remain unclear. This study aims to investigate the link between AMI to pain, functional performance and how an acute treatment can affect functional performance and pain.

Description:

Patellofemoral pain (PFP) is one of the most frequently diagnosed conditions in patients with knee complaints.

Studies investigating the therapeutic effect on PFP revealed that the majority of patients with PFP were still suffering of knee pain after 5 to 8 years, despite initially received treatment and education, indicating that the current treatments fail to prevent the chronicity of symptoms. Considering that current treatment-strategies of patients with PFP seem to be unable to avoid the development of chronic symptoms, the question arises if the underlying factors of PFP are understood sufficiently.

In contrary to the current broad body of literature on weakness, potentially underlying factors which might influence or even lead to PFP, such arthrogenic muscle inhibition (AMI) or the break phenomenon remain understudied.

Pain in PFP has been proven to be linked to quadriceps strength deficit, gluteal strength deficits, knee stability, irregularities in the quadriceps torque curve, and functional performance. Bazett et al. (2011) described that pain "is more than a symptom and might play a role in the etiology or progression of PFP". Furthermore, pain seems to play a crucial role in AMI. However, the correlation between pain and AMI in patients with PFP has not been investigated currently.

No assessment in isolation can provide a full picture of the problem. The combination of AMI, the break phenomenon with a biomechanical analysis might enable the determination of the impact of inhibition and strength on biomechanical changes. In addition, it might provide an answer to whether AMI or weakness cause biomechanical alterations, which would help to optimise treatment approaches in PFP.

The PowersTM strap strap was developed with the aim of assisting lower limb kinematics, decreasing knee varus through supporting femoral abduction and external rotation. This treatment may potentially also directly improve functional performance. As the functional performance in participants with PFP after the application of the PowersTM strap has not been investigated, this study aims to analyse if there is a direct link between the application of the PowersTM strap to functional performance and pain.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 21
• Est. completion date: October 2017
• Est. primary completion date: September 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria for patients with PFP:

1. Reproducible pain with at least two of these activities: ascending or descending stairs or ramps, squatting, kneeling, prolonged sitting, hopping/ jumping, isometric quadriceps contraction or running

2. Clearly defined pain location in the peripatellar region

3. Reports of pain greater than 1 month duration.

4. They are able to perform squatting, running and MVC task- Participant response

5. Age range: 18-45 years old

Inclusion criteria for healthy volunteers:

1. Healthy and without any previous lower limb injuries

2. The participant is able to perform squatting, running and MVC task

Exclusion Criteria:

1. Previous history of knee surgery

2. Previous history of (traumatic) patella dislocation or instability

3. Previous history of ligamentous instabilities

4. Previous history of traumatic, inflammatory or infectious pathology in the lower extremity

5. Previous history of internal derangement or other causes

6. Previous diagnosed degenerative conditions in the knee

7. Exclusion if patients cannot perform running, step down, or MVC task.

8. Exclusion criteria for the healthy control group are: clinical evidence of other knee injury or knee pain, and current significant injury affecting other lower extremity joints.

Related Conditions & MeSH terms

• Anterior Knee Pain
• Patellofemoral Pain

Intervention

Other:
• PowersTM strap
The powers strap aims to decrease knee varus through supporting femoral abduction and external rotation. Participants will wear the Powers strap while performing functional tasks (running, squatting, single leg step down).

Locations

Country	Name	City	State
United Kingdom	University of Salford	Salford	Greater Manchester

Sponsors (1)

Lead Sponsor	Collaborator
University of Salford

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Influence of Powers strap	The influence of the Powers strap on functional performance will be investigated by analysing hip and knee kinematics and kinetics with and without the Powers strap in participants with PFP	1 day